Drug Detail:Ticagrelor (Ticagrelor [ tye-ka-grel-or ])
Drug Class: Platelet aggregation inhibitors
Ticagrelor Levels and Effects while Breastfeeding
Summary of Use during Lactation
No published information is available on the use of ticagrelor during breastfeeding. Because ticagrelor and its active metabolite are more than 99% bound to plasma proteins, the amount in milk is likely to be low. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. If it is used by a nursing mother, monitor the infant for bruising and bleeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Aspirin
Substance Identification
Substance Name
Ticagrelor
CAS Registry Number
274693-27-5
Drug Class
-
Breastfeeding
-
Lactation
-
Purinergic P2Y Receptor Antagonists
-
Platelet Aggregation Inhibitors
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification